Contemporary clinical role of echocardiography in patients with advanced heart failure.
Advanced heart failure
Clinical echocardiography
Echocardiography
Heart failure
Left ventricular assist device
Journal
Heart failure reviews
ISSN: 1573-7322
Titre abrégé: Heart Fail Rev
Pays: United States
ID NLM: 9612481
Informations de publication
Date de publication:
19 Sep 2024
19 Sep 2024
Historique:
accepted:
26
08
2024
medline:
20
9
2024
pubmed:
20
9
2024
entrez:
19
9
2024
Statut:
aheadofprint
Résumé
Echocardiography represents an essential tool for imagers and clinical cardiologists in the management of patients with heart failure. Advanced heart failure (AdHF) is a more severe and, typically, later stage of HF that exposes patients to a high risk of adverse outcomes, with a 1-year mortality rate of around 50%. Currently, several therapies are available to improve the outcomes of these patients, reduce their mortality rate, and, possibly, delay the need for advanced therapies such as heart transplant and long-term mechanical circulatory support. When accurately performed and interpreted, echocardiography provides crucial information to properly tailor medical and device therapy of patients with AdHF and to identify those at even higher risk. In this review, we present the state of the art of echocardiography applications in the clinical management of patients with AdHF. We will discuss the role of echocardiography chronologically, beginning with the prediction of AdHF, proceeding through diagnosis, and detailing how echocardiography informs clinical decision-making, before concluding with indications for advanced therapies.
Identifiants
pubmed: 39298044
doi: 10.1007/s10741-024-10434-6
pii: 10.1007/s10741-024-10434-6
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Tomasoni D, Adamo M, Anker MS, von Haehling S, Coats AJS, Metra M (2020) Heart failure in the last year: progress and perspective. ESC Heart Fail 7(6):3505–3530. https://doi.org/10.1002/ehf2.13124
doi: 10.1002/ehf2.13124
pubmed: 33277825
pmcid: 7754751
Agostoni P, Corrà U, Cattadori G et al (2013) Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 167(6):2710–2718
doi: 10.1016/j.ijcard.2012.06.113
pubmed: 22795401
Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB et al (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113(11):1424–1433. https://doi.org/10.1161/CIRCULATIONAHA.105.584102
doi: 10.1161/CIRCULATIONAHA.105.584102
pubmed: 16534009
Kochav SM, Flores RJ, Truby LK, Topkara VK (2018) Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in patients with advanced heart failure: insights from the ESCAPE Trial. J Card Fail 24(7):453–459. https://doi.org/10.1016/j.cardfail.2018.03.008
doi: 10.1016/j.cardfail.2018.03.008
pubmed: 29597051
Jaarsma T, Hill L, Bayes-Genis A, La Rocca HB, Castiello T, Čelutkienė J et al (2021) Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 23(1):157–174. https://doi.org/10.1002/ejhf.2008
doi: 10.1002/ejhf.2008
pubmed: 32945600
Fraser AG, Monaghan MJ, van der Steen AFW, Sutherland GR (2022) A concise history of echocardiography: timeline, pioneers, and landmark publications. Eur Heart J Cardiovasc Imaging 23(9):1130–1143. https://doi.org/10.1093/ehjci/jeac111
doi: 10.1093/ehjci/jeac111
pubmed: 35762885
pmcid: 9365309
Teichholz LE, Cohen MV, Sonnenblick EH, Gorlin R (1974) Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy. N Engl J Med 291(23):1220–1226. https://doi.org/10.1056/NEJM197412052912304
doi: 10.1056/NEJM197412052912304
pubmed: 4473184
Pastore MC, Mandoli GE, Aboumarie HS, Santoro C, Bandera F, D’Andrea A et al (2020) Working Group of Echocardiography of the Italian Society of Cardiology. Basic and advanced echocardiography in advanced heart failure: an overview. Heart Fail Rev 25(6):937–948. https://doi.org/10.1007/s10741-019-09865-3
doi: 10.1007/s10741-019-09865-3
pubmed: 31617033
Melillo E, Masarone D, Oh JK, Verrengia M, Valente F, Vastarella R et al (2021) Echocardiography in advanced heart failure for diagnosis, management, and prognosis. Heart Fail Clin 17(4):547–560. https://doi.org/10.1016/j.hfc.2021.05.001
doi: 10.1016/j.hfc.2021.05.001
pubmed: 34511204
Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV et al (2021) Advanced heart failure epidemiology and outcomes: a population-based study. JACC Heart Fail 9(10):722–732
doi: 10.1016/j.jchf.2021.05.009
pubmed: 34391736
pmcid: 8487916
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368
doi: 10.1093/eurheartj/ehab368
pubmed: 34447992
Pagnesi M, Lombardi CM, Chiarito M, Stolfo D, Baldetti L, Loiacono F et al (2022) Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry. Eur J Heart Fail 24(9):1493–1503. https://doi.org/10.1002/ejhf.2561
doi: 10.1002/ejhf.2561
pubmed: 35603658
Kalogeropoulos AP, Samman-Tahhan A, Hedley JS, McCue AA, Bjork JB, Markham DW et al (2017) Progression to stage D heart failure among outpatients with stage c heart failure and reduced ejection fraction. JACC Heart Fail 5(7):528–537. https://doi.org/10.1016/j.jchf.2017.02.020
doi: 10.1016/j.jchf.2017.02.020
pubmed: 28624484
Subramaniam AV, Weston SA, Killian JM, Schulte PJ, Roger VL, Redfield MM et al (2022) Development of advanced heart failure: a population-based study. Circ Heart Fail 15(5):e009218. https://doi.org/10.1161/CIRCHEARTFAILURE.121.009218
doi: 10.1161/CIRCHEARTFAILURE.121.009218
pubmed: 35332793
pmcid: 9117446
Cleland JGF, Pellicori P (2021) To master heart failure, first master congestion. Lancet 398(10304):935–936
doi: 10.1016/S0140-6736(21)01914-0
pubmed: 34461039
Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P et al (2019) The use of diuretics in heart failure with congestion - a position statement from the heart failure association of the european society of cardiology. Eur J Heart Fail 21(2):137–155. https://doi.org/10.1002/ejhf.1369
doi: 10.1002/ejhf.1369
pubmed: 30600580
Lee HF, Hsu LA, Chang CJ, Chan YH, Wang CL, Ho WJ et al (2014) Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure. Int J Cardiovasc Imaging 30(7):1289–1295. https://doi.org/10.1007/s10554-014-0468-y
doi: 10.1007/s10554-014-0468-y
pubmed: 24939288
Pellicori P, Shah P, Cuthbert J, Urbinati A, Zhang J, Kallvikbacka-Bennett A et al (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. Eur J Heart Fail 21(7):904–916. https://doi.org/10.1002/ejhf.1383
doi: 10.1002/ejhf.1383
pubmed: 30666769
Beigel R, Cercek B, Arsanjani R, Siegel RJ (2014) Echocardiography in the use of noninvasive hemodynamic monitoring. J Crit Care 29(1):184.e1-184.e1848
doi: 10.1016/j.jcrc.2013.09.003
pubmed: 24135014
Ammirati E, Marchetti D, Colombo G, Pellicori P, Gentile P, D’Angelo L et al (2024) Estimation of right atrial pressure by ultrasound-assessed jugular vein distensibility in patients with heart failure. Circ Heart Fail 17(2):e010973. https://doi.org/10.1161/CIRCHEARTFAILURE.123.010973
doi: 10.1161/CIRCHEARTFAILURE.123.010973
pubmed: 38299348
Mullens W, Borowski AG, Curtin RJ, Thomas JD, Tang WH (2009) Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation 119(1):62–70
doi: 10.1161/CIRCULATIONAHA.108.779223
pubmed: 19075104
München Barth F, Beck-da-Silva L, Ghisleni EC, Butzke M, Scolari FL, da Silva MB et al (2023) Lung ultrasound in congestion assessment of patients with advanced heart failure referred for heart transplant: correlations with right heart catheterization findings. Am Heart J Plus 5(26):100250. https://doi.org/10.1016/j.ahjo.2023.100250
doi: 10.1016/j.ahjo.2023.100250
Ohara H, Yoshihisa A, Ishibashi S, Matsuda M, Yamadera Y, Sugawara Y, Ichijo Y, Sato Y, Misaka T, Sato T, Oikawa M, Kobayashi A, Takeishi Y (2023) Hepatic venous stasis index reflects hepatic congestion and predicts adverse outcomes in patients with heart failure. J Am Heart Assoc 12(12):e029857. https://doi.org/10.1161/JAHA.122.029857
doi: 10.1161/JAHA.122.029857
pubmed: 37301763
pmcid: 10356015
Ohara H, Yoshihisa A, Horikoshi Y, Ishibashi S, Matsuda M, Yamadera Y, Sugawara Y, Ichijo Y, Hotsuki Y, Watanabe K, Sato Y, Misaka T, Kaneshiro T, Oikawa M, Kobayashi A, Takeishi Y (2022) Renal venous stasis index reflects renal congestion and predicts adverse outcomes in patients with heart failure. Front Cardiovasc Med 7(9):772466. https://doi.org/10.3389/fcvm.2022.772466
doi: 10.3389/fcvm.2022.772466
Burgos LM, Baro Vila R, Goyeneche A, Muñoz F, Spaccavento A, Fasan MA et al (2022) Design and rationale of the inferior vena CAVA and Lung UltraSound-guided therapy in Acute Heart Failure (CAVAL US-AHF Study): a randomised controlled trial. Open Heart 9(2):e002105. https://doi.org/10.1136/openhrt-2022-002105
doi: 10.1136/openhrt-2022-002105
pubmed: 36344108
pmcid: 9644364
Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T et al (2021) Patient profiling in heart failure for tailoring medical therapy. A consensus document of the heart failure association of the european society of cardiology. Eur J Heart Fail 23(6):872–881. https://doi.org/10.1002/ejhf.2206
doi: 10.1002/ejhf.2206
pubmed: 33932268
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J et al (2020) Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382(20):1883–1893. https://doi.org/10.1056/NEJMoa1915928
doi: 10.1056/NEJMoa1915928
pubmed: 32222134
Perros F, de Man FS, Bogaard HJ, Antigny F, Simonneau G, Bonnet S (2017) Use of β-blockers in pulmonary hypertension. Circ Heart Fail 10(4):e003703. https://doi.org/10.1161/CIRCHEARTFAILURE.116.003703
doi: 10.1161/CIRCHEARTFAILURE.116.003703
pubmed: 28364092
Nuzzi V, Cannatà A, Pellicori P, Manca P, Stolfo D, Gregorio C et al (2023) Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications. Clin Res Cardiol 112(3):419–430. https://doi.org/10.1007/s00392-022-02126-8
doi: 10.1007/s00392-022-02126-8
pubmed: 36385396
Jobs A, Vonthein R, König IR, Schäfer J, Nauck M, Haag S et al (2020) Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA-ADHF-DZHK10 trial. ESC Heart Fail 7(3):973–983. https://doi.org/10.1002/ehf2.12598
doi: 10.1002/ehf2.12598
pubmed: 31991063
pmcid: 7261559
Lewis JF, Kuo LC, Nelson JG, Limacher MC, Quinones MA (1984) Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. Circulation 70(3):425–431. https://doi.org/10.1161/01.cir.70.3.425
doi: 10.1161/01.cir.70.3.425
pubmed: 6744546
Ameri P, Bertero E, Maack C, Teerlink JR, Rosano G, Metra M (2021) Medical treatment of heart failure with reduced ejection fraction: the dawn of a new era of personalized treatment? Eur Heart J Cardiovasc Pharmacother 7(6):539–546. https://doi.org/10.1093/ehjcvp/pvab033
doi: 10.1093/ehjcvp/pvab033
pubmed: 34037742
Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM (2004) Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail 10(4):285–291. https://doi.org/10.1016/j.cardfail.2003.12.006
doi: 10.1016/j.cardfail.2003.12.006
pubmed: 15309693
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD et al (2021) Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure. N Engl J Med 384(2):105–116. https://doi.org/10.1056/NEJMoa2025797
doi: 10.1056/NEJMoa2025797
pubmed: 33185990
Vader JM, Givertz MM, Starling RC, McNulty SE, Anstrom KJ, Desvigne-Nickens P et al (2022) Tolerability of sacubitril/valsartan in patients with advanced heart failure: analysis of the LIFE trial Run-In. JACC Heart Fail 10(7):449–456. https://doi.org/10.1016/j.jchf.2022.04.013
doi: 10.1016/j.jchf.2022.04.013
pubmed: 35772853
Njoroge JN, Teerlink JR (2021) Pathophysiology and therapeutic approaches to acute decompensated heart failure. Circ Res 128(10):1468–1486. https://doi.org/10.1161/CIRCRESAHA.121.318186
doi: 10.1161/CIRCRESAHA.121.318186
pubmed: 33983837
pmcid: 8126502
Lu DY, Fang Q, Bibby D, Arora B, Schiller NB (2022) Association of systemic vascular resistance analog and cardiovascular outcomes: the heart and soul study. J Am Heart Assoc 11(17):e026016. https://doi.org/10.1161/JAHA.122.026016
doi: 10.1161/JAHA.122.026016
pubmed: 36000438
pmcid: 9496441
Abbas AE, Fortuin FD, Patel B, Moreno CA, Schiller NB, Lester SJ (2004) Noninvasive measurement of systemic vascular resistance using Doppler echocardiography. J Am Soc Echocardiogr 17(8):834–838. https://doi.org/10.1016/j.echo.2004.04.008
doi: 10.1016/j.echo.2004.04.008
pubmed: 15282486
Cooper HA, Gersh BJ (1998) Treatment of chronic mitral regurgitation. Am Heart J 135(6 Pt 1):925–936. https://doi.org/10.1016/s0002-8703(98)70056-0
doi: 10.1016/s0002-8703(98)70056-0
pubmed: 9630095
Garascia A, Palazzini M, Tedeschi A, Sacco A, Oliva F, Gentile P (2023) Advanced heart failure: from definitions to therapeutic options. Eur Heart J Suppl 25(Suppl C):C283–C291. https://doi.org/10.1093/eurheartjsupp/suad028
doi: 10.1093/eurheartjsupp/suad028
pubmed: 37125285
pmcid: 10132575
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD et al (2021) Effect of ejection fraction on clinical outcomes in patients treated with omecamtiv mecarbil in GALACTIC-HF. J Am Coll Cardiol 78(2):97–108. https://doi.org/10.1016/j.jacc.2021.04.065
doi: 10.1016/j.jacc.2021.04.065
pubmed: 34015475
Metra M, Pagnesi M, Claggett BL, Díaz R, Felker GM, McMurray JJV et al (2022) Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial. Eur Heart J 43(48):5006–5016. https://doi.org/10.1093/eurheartj/ehac293
doi: 10.1093/eurheartj/ehac293
pubmed: 35675469
pmcid: 9769958
Usman MS, Januzzi JL, Anker SD, Salman A, Parikh PB, Adamo M, Filippatos G, Khan MS, Lala A, Verma S, Metra M, Butler J (2024) The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: systematic review and meta-analysis. Eur J Heart Fail 26(2):373–382. https://doi.org/10.1002/ejhf.3129
doi: 10.1002/ejhf.3129
pubmed: 38235936
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361(14):1329–1338. https://doi.org/10.1056/NEJMoa0906431
doi: 10.1056/NEJMoa0906431
pubmed: 19723701
Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM et al (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379(24):2307–2318. https://doi.org/10.1056/NEJMoa1806640
doi: 10.1056/NEJMoa1806640
pubmed: 30280640
Gras D, Leclercq C, Tang AS, Bucknall C, Luttikhuis HO, Kirstein-Pedersen A (2002) Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 4(3):311–320. https://doi.org/10.1016/s1388-9842(02)00018-1
doi: 10.1016/s1388-9842(02)00018-1
pubmed: 12034157
Stankovic I, Prinz C, Ciarka A, Daraban AM, Kotrc M, Aarones M et al (2016) Relationship of visually assessed apical rocking and septal flash to response and long-term survival following cardiac resynchronization therapy (PREDICT-CRT). Eur Heart J Cardiovasc Imaging 17(3):262–269. https://doi.org/10.1093/ehjci/jev288
doi: 10.1093/ehjci/jev288
pubmed: 26588984
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J et al (2008) Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117(20):2608–2616. https://doi.org/10.1161/CIRCULATIONAHA.107.743120
doi: 10.1161/CIRCULATIONAHA.107.743120
pubmed: 18458170
Gorcsan J 3rd, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA et al (2008) Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting–a report from the american society of echocardiography dyssynchrony writing group endorsed by the heart rhythm society. J Am Soc Echocardiogr 21(3):191–213. https://doi.org/10.1016/j.echo.2008.01.003
doi: 10.1016/j.echo.2008.01.003
pubmed: 18314047
Šipula D, Kozák M, Šipula J, Homza M, Plášek J (2019) Cardiac strains as a tool for optimization of cardiac resynchronization therapy in non-responders: a pilot study. Open Med (Wars) 10(14):945–952. https://doi.org/10.1515/med-2019-0111
doi: 10.1515/med-2019-0111
Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N et al (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379(24):2297–2306. https://doi.org/10.1056/NEJMoa1805374
doi: 10.1056/NEJMoa1805374
pubmed: 30145927
Ooms JF, Bouwmeester S, Debonnaire P, Nasser R, Voigt JU, Schotborgh MA et al (2022) Transcatheter edge-to-edge repair in proportionate versus disproportionate functional mitral regurgitation. J Am Soc Echocardiogr 35(1):105-115.e8. https://doi.org/10.1016/j.echo.2021.08.002
doi: 10.1016/j.echo.2021.08.002
pubmed: 34389469
ClinicalTrials.gov. (2022). (NCT number): NCT05292716. Mitral regurgitation treatment in advanced heart failure (MITRADVANCE). https://clinicaltrials.gov/study/NCT05292716 . Accessed 10 May 2024
Ikeda Y, Inomata T, Iida Y, Iwamoto-Ishida M, Nabeta T, Ishii S, Sato T, Yanagisawa T, Mizutani T, Naruke T, Koitabashi T, Takeuchi I, Nishii M, Ako J (2016) Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy. Heart Vessels 31(4):545–554. https://doi.org/10.1007/s00380-015-0648-2
doi: 10.1007/s00380-015-0648-2
pubmed: 25686768
Sisakian H, Shahnazaryan S, Pepoyan S, Minasyan A, Martirosyan G, Hovhannisyan M et al (2022) Reduction of hospitalization and mortality by echocardiography-guided treatment in advanced heart failure. J Cardiovasc Dev Dis 9(3):74. https://doi.org/10.3390/jcdd9030074
doi: 10.3390/jcdd9030074
pubmed: 35323622
pmcid: 8953534
Aimo A, Vergaro G, Castiglione V, Barison A, Pasanisi E, Petersen C et al (2017) Effect of sex on reverse remodeling in chronic systolic heart failure. JACC Heart Fail 5(10):735–742. https://doi.org/10.1016/j.jchf.2017.07.011
doi: 10.1016/j.jchf.2017.07.011
pubmed: 28958348
Cannata A, Manca P, Nuzzi V, Gregorio C, Artico J, Gentile P (2020) Sex-specific prognostic implications in dilated cardiomyopathy after left ventricular reverse remodeling. J Clin Med 9(8):2426. https://doi.org/10.3390/jcm9082426
doi: 10.3390/jcm9082426
pubmed: 32751220
pmcid: 7464387
Wang X, Zhao XZ, Wang XW, Cao LY, Lu B, Wang ZH, Zhang W, Ti Y, Zhong M (2024) Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta-analysis. ESC Heart Fail 11(3):1352–1376. https://doi.org/10.1002/ehf2.14714
doi: 10.1002/ehf2.14714
pubmed: 38419326
pmcid: 11098670
Manca P, Stolfo D, Merlo M, Gregorio C, Cannatà A, Ramani F et al (2022) Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 24(7):1171–1179. https://doi.org/10.1002/ejhf.2512
doi: 10.1002/ejhf.2512
pubmed: 35460146
Nuzzi V, Raafs A, Manca P, Henkens MTHM, Gregorio C, Boscutti A et al (2023) Left atrial reverse remodeling in dilated cardiomyopathy. J Am Soc Echocardiogr 36(2):154–162. https://doi.org/10.1016/j.echo.2022.10.017
doi: 10.1016/j.echo.2022.10.017
pubmed: 36332803
Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G et al (2017) Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 18(12):1301–1310. https://doi.org/10.1093/ehjci/jex244
doi: 10.1093/ehjci/jex244
pubmed: 29045589
Van De Heyning CM, Magne J, Cosyns B (2019) Is cardiac magnetic resonance imaging the new “gold standard” for quantitation of mitral regurgitation? A critical appraisal. J Am Soc Echocardiogr 32(1):163. https://doi.org/10.1016/j.echo.2018.08.014
doi: 10.1016/j.echo.2018.08.014
pubmed: 30337187
Argulian E, Narula J (2021) Advanced cardiovascular imaging in clinical heart failure. JACC Heart Fail 9(10):699–709. https://doi.org/10.1016/j.jchf.2021.06.016
doi: 10.1016/j.jchf.2021.06.016
pubmed: 34391742
Tsang W, Salgo IS, Medvedofsky D, Takeuchi M, Prater D, Weinert L et al (2016) Transthoracic 3D echocardiographic left heart chamber quantification using an automated adaptive analytics algorithm. JACC Cardiovasc Imaging 9(7):769–782. https://doi.org/10.1016/j.jcmg.2015.12.020
doi: 10.1016/j.jcmg.2015.12.020
pubmed: 27318718
Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA (2000) Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 102(10):1158–64. https://doi.org/10.1161/01.cir.102.10.1158
doi: 10.1161/01.cir.102.10.1158
pubmed: 10973846
Raafs AG, Boscutti A, Henkens MTHM, van den Broek WWA, Verdonschot JAJ, Weerts J et al (2022) Global longitudinal strain is incremental to left ventricular ejection fraction for the prediction of outcome in optimally treated dilated cardiomyopathy patients. J Am Heart Assoc 11(6):e024505. https://doi.org/10.1161/JAHA.121.024505
doi: 10.1161/JAHA.121.024505
pubmed: 35253464
pmcid: 9075270
Sengeløv M, Jørgensen PG, Jensen JS, Bruun NE, Olsen FJ, Fritz-Hansen T et al (2015) Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction. JACC Cardiovasc Imaging 8(12):1351–1359. https://doi.org/10.1016/j.jcmg.2015.07.013
doi: 10.1016/j.jcmg.2015.07.013
pubmed: 26577264
Cameli M, Mondillo S, Righini FM, Lisi M, Dokollari A, Lindqvist P et al (2016) Left ventricular deformation and myocardial fibrosis in patients with advanced heart failure requiring transplantation. J Card Fail 22(11):901–907. https://doi.org/10.1016/j.cardfail.2016.02.012
doi: 10.1016/j.cardfail.2016.02.012
pubmed: 26952240
Carluccio E, Biagioli P, Lauciello R, Zuchi C, Mengoni A, Bardelli G et al (2019) Superior prognostic value of right ventricular free wall compared to global longitudinal strain in patients with heart failure. J Am Soc Echocardiogr 32(7):836-844.e1. https://doi.org/10.1016/j.echo.2019.02.011
doi: 10.1016/j.echo.2019.02.011
pubmed: 30979539
Cameli M, Lisi M, Righini FM, Tsioulpas C, Bernazzali S, Maccherini M et al (2012) Right ventricular longitudinal strain correlates well with right ventricular stroke work index in patients with advanced heart failure referred for heart transplantation. J Card Fail 18(3):208–215. https://doi.org/10.1016/j.cardfail.2011.12.002
doi: 10.1016/j.cardfail.2011.12.002
pubmed: 22385941
Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T et al (2018) Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19(6):591–600. https://doi.org/10.1093/ehjci/jey042
doi: 10.1093/ehjci/jey042
pubmed: 29596561
Deferm S, Martens P, Verbrugge FH, Bertrand PB, Dauw J, Verhaert D et al. (2020) LA mechanics in decompensated heart failure: insights from strain echocardiography with invasive hemodynamics. JACC Cardiovasc Imaging. 13(5):1107–1115. https://doi.org/10.1016/j.jcmg.2019.12.008 . Erratum in: JACC Cardiovasc Imaging. 2020 Aug;13(8):1862. https://doi.org/10.1016/j.jcmg.2020.07.001
Boe E, Skulstad H, Smiseth OA (2019) Myocardial work by echocardiography: a novel method ready for clinical testing. Eur Heart J Cardiovasc Imaging 20(1):18–20. https://doi.org/10.1093/ehjci/jey156
doi: 10.1093/ehjci/jey156
pubmed: 30376059
Hedwig F, Nemchyna O, Stein J, Knosalla C, Merke N, Knebel F et al (2021) Myocardial work assessment for the prediction of prognosis in advanced heart failure. Front Cardiovasc Med 18(8):691611. https://doi.org/10.3389/fcvm.2021.691611
doi: 10.3389/fcvm.2021.691611
Lakatos BK, Rako Z, Szijártó Á, da Rocha BRB, Richter MJ, Fábián A et al (2024) Right ventricular pressure-strain relationship-derived myocardial work reflects contractility: validation with invasive pressure-volume analysis. J Heart Lung Transplant 43(7):1183–1187. https://doi.org/10.1016/j.healun.2024.03.007
doi: 10.1016/j.healun.2024.03.007
pubmed: 38508504
Dharmavaram N, Hess T, Jaeger H, Smith J, Hermsen J, Murray D et al (2021) National trends in heart donor usage rates: are we efficiently transplanting more hearts? J Am Heart Assoc 10(15):e019655. https://doi.org/10.1161/JAHA.120.019655
doi: 10.1161/JAHA.120.019655
pubmed: 34315285
pmcid: 8475695
Cameli M, Pastore MC, Mandoli GE, Nistor D, Lisi E, Tok ÖÖ et al (2019) Prognosis and risk stratification of patients with advanced heart failure (from PROBE). Am J Cardiol 124(1):55–62. https://doi.org/10.1016/j.amjcard.2019.03.041
doi: 10.1016/j.amjcard.2019.03.041
pubmed: 31047653
Tan C, Rubenson D, Srivastava A, Mohan R, Smith MR, Billick K et al (2017) Left ventricular outflow tract velocity time integral outperforms ejection fraction and Doppler-derived cardiac output for predicting outcomes in a select advanced heart failure cohort. Cardiovasc Ultrasound 15(1):18. https://doi.org/10.1186/s12947-017-0109-4
doi: 10.1186/s12947-017-0109-4
pubmed: 28673293
pmcid: 5496262
Leclercq C, Burri H, Delnoy PP, Rinaldi CA, Sperzel J, Calò L et al (2023) Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial. Europace. 25(10):euad294. https://doi.org/10.1093/europace/euad294
doi: 10.1093/europace/euad294
pubmed: 37776313
pmcid: 10561537
Theochari CA, Michalopoulos G, Oikonomou EK, Giannopoulos S, Doulamis IP, Villela MA et al (2018) Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis. Ann Cardiothorac Surg 7(1):3–11. https://doi.org/10.21037/acs.2017.09.18
doi: 10.21037/acs.2017.09.18
pubmed: 29492379
pmcid: 5827119
Mehra MR, Nayak A, Morris AA, Lanfear DE, Nemeh H, Desai S et al (2022) Prediction of survival after implantation of a fully magnetically levitated left ventricular assist device. JACC Heart Fail 10(12):948–959. https://doi.org/10.1016/j.jchf.2022.08.002
doi: 10.1016/j.jchf.2022.08.002
pubmed: 36456068
Selamet Tierney ES, Hollenbeck-Pringle D, Lee CK, Altmann K, Dunbar-Masterson C, Golding F et al (2017) Reproducibility of left ventricular dimension versus area versus volume measurements in pediatric patients with dilated cardiomyopathy. Circ Cardiovasc Imaging 10(11):e006007. https://doi.org/10.1161/CIRCIMAGING.116.006007
doi: 10.1161/CIRCIMAGING.116.006007
pubmed: 29133477
Calvieri C, Riva A, Sturla F, Dominici L, Conia L, Gaudio C et al (2023) Left ventricular adverse remodeling in ischemic heart disease: emerging cardiac magnetic resonance imaging biomarkers. J Clin Med 12(1):334. https://doi.org/10.3390/jcm12010334
doi: 10.3390/jcm12010334
pubmed: 36615133
pmcid: 9820966
Manca P, Nuzzi V, Cannatà A, Castrichini M, Bromage DI, De Luca A et al (2022) The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child. Heart Fail Rev 27(5):1795–1805. https://doi.org/10.1007/s10741-022-10229-7
doi: 10.1007/s10741-022-10229-7
pubmed: 35315505
pmcid: 9388461
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003
doi: 10.1016/j.echo.2014.10.003
pubmed: 25559473
Hayek S, Sims DB, Markham DW, Butler J, Kalogeropoulos AP (2014) Assessment of right ventricular function in left ventricular assist device candidates. Circ Cardiovasc Imaging 7(2):379–389. https://doi.org/10.1161/CIRCIMAGING.113.001127
doi: 10.1161/CIRCIMAGING.113.001127
pubmed: 24642920
pmcid: 3961845
Kapelios CJ, Lund LH, Wever-Pinzon O, Selzman CH, Myers SL, Cantor RS et al (2022) Right heart failure following left ventricular device implantation: natural history, risk factors, and outcomes: an analysis of the STS INTERMACS database. Circ Heart Fail 15(6):e008706. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008706
doi: 10.1161/CIRCHEARTFAILURE.121.008706
pubmed: 35658464
pmcid: 9233112
Grant AD, Smedira NG, Starling RC, Marwick TH (2012) Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol 60(6):521–528. https://doi.org/10.1016/j.jacc.2012.02.073
doi: 10.1016/j.jacc.2012.02.073
pubmed: 22858287
Stricagnoli M, Sciaccaluga C, Mandoli GE, Rizzo L, Sisti N, Aboumarie HS et al (2022) Clinical, echocardiographic and hemodynamic predictors of right heart failure after LVAD placement. Int J Cardiovasc Imaging 38(3):561–570. https://doi.org/10.1007/s10554-021-02433-7
doi: 10.1007/s10554-021-02433-7
pubmed: 34661853
Chriqui LE, Monney P, Kirsch M, Tozzi P (2021) Prediction of right ventricular failure after left ventricular assist device implantation in patients with heart failure: a meta-analysis comparing echocardiographic parameters. Interact Cardiovasc Thorac Surg 33(5):784–792. https://doi.org/10.1093/icvts/ivab177
doi: 10.1093/icvts/ivab177
pubmed: 34368839
pmcid: 8691721
Shimada YJ, Shiota M, Siegel RJ, Shiota T (2010) Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study. J Am Soc Echocardiogr 23(9):943–953. https://doi.org/10.1016/j.echo.2010.06.029
doi: 10.1016/j.echo.2010.06.029
pubmed: 20797527
Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R et al (2010) Multimodality comparison of quantitative volumetric analysis of the right ventricle. JACC Cardiovasc Imaging 3(1):10–18. https://doi.org/10.1016/j.jcmg.2009.09.017
doi: 10.1016/j.jcmg.2009.09.017
pubmed: 20129525
De Potter T, Weytjens C, Motoc A, Luchian ML, Scheirlynck E, Roosens B et al (2021) Feasibility, reproducibility and validation of right ventricular volume and function assessment using three-dimensional echocardiography. Diagnostics (Basel) 11(4):699. https://doi.org/10.3390/diagnostics11040699
doi: 10.3390/diagnostics11040699
pubmed: 33919794
Kiernan MS, French AL, DeNofrio D, Parmar YJ, Pham DT, Kapur NK et al (2015) Preoperative three-dimensional echocardiography to assess risk of right ventricular failure after left ventricular assist device surgery. J Card Fail 21(3):189–197. https://doi.org/10.1016/j.cardfail.2014.12.009
doi: 10.1016/j.cardfail.2014.12.009
pubmed: 25535957
Riebandt J, Schaefer A, Wiedemann D, Schlöglhofer T, Laufer G, Sandner S et al (2021) Concomitant cardiac surgery procedures during left ventricular assist device implantation: single-centre experience. Ann Cardiothorac Surg. 10(2):248–254. https://doi.org/10.21037/acs-2020-cfmcs-30
doi: 10.21037/acs-2020-cfmcs-30
pubmed: 33842219
pmcid: 8033261
Veen KM, Mokhles MM, Soliman O, de By TMMH, Mohacsi P, Schoenrath F et al (2021) Clinical impact and “natural” course of uncorrected tricuspid regurgitation after implantation of a left ventricular assist device: an analysis of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS). Eur J Cardiothorac Surg 59(1):207–216. https://doi.org/10.1093/ejcts/ezaa294
doi: 10.1093/ejcts/ezaa294
pubmed: 33038216
Gulati G, Grandin EW, Kennedy K, Cabezas F, DeNofrio DD, Kociol R et al (2019) Preimplant phosphodiesterase-5 inhibitor use is associated with higher rates of severe early right heart failure after left ventricular assist device implantation. Circ Heart Fail 12(6):e005537. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005537
doi: 10.1161/CIRCHEARTFAILURE.118.005537
pubmed: 31181953
pmcid: 6624075
Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL et al (2008) PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 1(4):213–219. https://doi.org/10.1161/CIRCHEARTFAILURE.108.796789
doi: 10.1161/CIRCHEARTFAILURE.108.796789
pubmed: 19808294
pmcid: 4001820
Albani S, Stolfo D, Venkateshvaran A, Chubuchny V, Biondi F, De Luca A et al (2022) Echocardiographic biventricular coupling index to predict precapillary pulmonary hypertension. J Am Soc Echocardiogr 35(7):715–726. https://doi.org/10.1016/j.echo.2022.02.003
doi: 10.1016/j.echo.2022.02.003
pubmed: 35158052